Abstract
The severity, duration, and reversibility of pentamidine induced bronchial narrowing was studied with and without pretreatment with nebulised terbutaline 10 mg in an open study of 40 patients seropositive for the human immunodeficiency virus (HIV). All subjects received pentamidine 300 mg in 5 ml water via an Acorn System 22 jet nebuliser. The forced expiratory volume in one second (FEV1) fell in all 20 patients given pentamidine alone, the mean maximum fall being 20.6%. In the 20 patients given pentamidine preceded by nebulised terbutaline the mean maximum fall in FEV1 was 4%; three subjects had a fall in FEV1 of more than 10%.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beasley R., Rafferty P., Holgate S. T. Adverse reactions to the non-drug constituents of nebuliser solutions. Br J Clin Pharmacol. 1988 Mar;25(3):283–287. doi: 10.1111/j.1365-2125.1988.tb03305.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Montgomery A. B., Debs R. J., Luce J. M., Corkery K. J., Turner J., Brunette E. N., Lin E. T., Hopewell P. C. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987 Aug 29;2(8557):480–483. doi: 10.1016/s0140-6736(87)91794-6. [DOI] [PubMed] [Google Scholar]
- O'Doherty M. J., Thomas S., Page C., Barlow D., Bradbeer C., Nunan T. O., Bateman N. T. Differences in relative efficiency of nebulisers for pentamidine administration. Lancet. 1988 Dec 3;2(8623):1283–1286. doi: 10.1016/s0140-6736(88)92894-2. [DOI] [PubMed] [Google Scholar]
- Smith D. E., Herd D., Gazzard B. G. Reversible bronchoconstriction with nebulised pentamidine. Lancet. 1988 Oct 15;2(8616):905–905. doi: 10.1016/s0140-6736(88)92500-7. [DOI] [PubMed] [Google Scholar]
- Thomas S., O'Doherty M., Bateman N. Pneumocystis carinii pneumonia. BMJ. 1990 Jan 27;300(6719):211–212. doi: 10.1136/bmj.300.6719.211. [DOI] [PMC free article] [PubMed] [Google Scholar]